|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cardiovascular Disease in a Forward Military Hospital during Operation Iraqi Freedom: A Report from Deployed Cardiologists显示文摘 | Sullenberger Lance Gentlesk Philip J | 2008 | Military Medicine2008，，2： | 2 |
| 2 | Arterial biology for theinvestigation of the treatment effects of reducing cholesterol(ARBI-TER)2:a double-blind,placebo-controlled study of extended-re-lease niacin on atherosclerosis progression in secondary preventionpatients treated with statins显示文摘 | Taylor AJ Sullenberger LE Lee HJ | 2004 | Circulation2004，110，23： | 1 |
| 3 | Arterial biology for the investigation of the treatment effects of reducing cholesterol(ARBIFER2):A double-bind place bo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins显示文摘 | Taylor A J Sullenberger L E Lee H J | 2004 | Circulation2004，110，23： | 1 |
| 4 | Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins显示文摘 | TAYLOR A J SULLENBERGER A L E LEE H J | 2004 | Circulation2004，110，23： | 1 |
| 5 | The effect of 24 months ofcombination statin and extended-release niacin on carotid intima-media thickness:ARBITER 3显示文摘 | Taylor AJ Lee HJ Sullenberger LE | 2006 | Curr Med Res Opin2006，22，11： | 1 |
| 6 | Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double-blind, placebo controlled study of extended-release niacin on atherosclerosis progression in secondary prevention pa- tients treated with statins显示文摘 | Taylor A J Sullenberger L E Lee H J | 2004 | Circulation2004，110，23： | 1 |
| 7 | A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with stains显示文摘 | Taylor A J Sullenberger L E Lee H J | 2004 | Circulation2004，110，23： | 1 |
| 8 | Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2:a double-blind,placebo-controlled study of extendedrelease niacin on atherosclerosisprogression in secondary prevention patients treated with statins显示文摘 | Taylor AJ Sullenberger LE Lee HJ | | 0，，23： | 1 |
| 9 | Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins显示文摘 | TAYLOR A J SULLENBERGER LE LEE H J | 2004 | Circulation2004，110，23： | 1 |
| 10 | Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo controlled study of ex- tended-release niacin on atheroselerosis progression in secondary prevention patients treated with statins 显示文摘 | Taylor AJ Sullenberger LE Lee H J | 2004 | Circulation2004，110，23： | 1 |
| 11 | The effect of 24 months of combination statin and extended-release niacin on carotid intima‐media thickness: ARBITER 3*显示文摘 | Allen J. Taylor Hyun J. Lee Lance E. Sullenberger | 2006 | Current Medical Research and Opinion?2006，，11： | 1 |
| 12 | Arerial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 显示文摘 | Taylor AJ Sullenberger LE Lee HJ | 2004 | Circulation2004，110，9： | 1 |
| 13 | Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A Double-Blind, Placebo-Controlled Study of Extended-Release Niacin on Atherosclerosis Progression in Secondary Prevention Patients Treated With Statins显示文摘 | Allen J. Taylor Lance E. Sullenberger Hyun J. Lee Jeannie K. Lee Karen A. Grace | 2004 | Circulation2004，，23： | 1 |
| 14 | Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double-blind, placebo- controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins 显示文摘 | Taylor AJ Sullenberger LE Lee H J | 2004 | Circulation2004，110，23： | 1 |
| 15 | Arterial Biology for the Investiga- tion of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins 显示文摘 | Taylor AJ Sullenberger LE Lee H J | 2004 | Circula- tion2004，110，23： | 1 |
| 16 | Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2:A double-blind,placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins显示文摘 | Taylor AJ Sullenberger LE Lee HJ | 2004 | Circulation2004，110，： | 1 |
| 17 | A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins显示文摘 | Taylor A J Sullenberger L E Lee H J | 2004 | Circulation2004，110，23： | 1 |
| 18 | A comparison between patients treated at a combat support hospital in Iraq and a level I trauma center in the United States显示文摘 | Martin AS Karen Zink Lance Sullenberger | 2008 | J Trauma2008，64，2： | 1 |
| 19 | Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol(ARBITER)2:a double-blind,placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins 显示文摘 | Taylor AJ Sullenberger LE Lee HJ | 2004 | Circulation2004，110，23： | 1 |
| 20 | Relationship between glycemic status and progression of carotid intima- media thickness during treatment with combined statin and extended- release niacin in ARBITER 2 显示文摘 | Taylor A J Zhu D Sullenberger LE | 2007 | Vasc Health Risk Manag2007，3，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员